ReviewArthritis research & therapy2006
Human pregnancy safety for agents used to treat rheumatoid arthritis: adequacy of available information and strategies for developing post-marketing data.
Review in Arthritis research & therapy, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A systematic review of interventions to improve knowledge and self-management skills concerning contraception, pregnancy and breastfeeding in people with rheumatoid arthritis.Clinical rheumatology · 2016Pooled it
- Genetically proxied tumour necrosis factor inhibition and pregnancy-related maternal and foetal outcomes in the general population: a Mendelian randomization study.Rheumatology advances in practice · 2025Article
- Lupus nephritis: management challenges during pregnancy.Frontiers in nephrology · 2024Review
- Protective Effects of Interleukin-1 Blockade on Group BFrontiers in endocrinology · 2022Article
- Old and New Calcineurin Inhibitors in Lupus Nephritis.Journal of clinical medicine · 2021Review
- Planned Pregnancy in Kidney Transplantation. A Calculated Risk.Journal of personalized medicine · 2021Review
- Protocol of a prospective and multicentre China Teratology Birth Cohort (CTBC): association of maternal drug exposure during pregnancy with adverse pregnancy outcomes.BMC pregnancy and childbirth · 2021Article
- Rheumatologic Medication Use During Pregnancy.Obstetrics and gynecology · 2020Review
- The use of biologics for autoimmune rheumatic diseases in fertility and pregnancy.Obstetric medicine · 2020Review
- A multidisciplinary approach to reproductive healthcare in women with rheumatic disease.Irish journal of medical science · 2020Article
- Fetal Toxicity of Immunosuppressive Drugs in Pregnancy.Journal of clinical medicine · 2018Review
- Understanding the information needs of women with rheumatoid arthritis concerning pregnancy, post-natal care and early parenting: A mixed-methods study.BMC musculoskeletal disorders · 2015Article
- Inflammatory bowel diseases and human reproduction: a comprehensive evidence-based review.World journal of gastroenterology · 2014Review
- The safety of ketoprofen in different ages.Journal of pharmacology & pharmacotherapeutics · 2013Article
- Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug use.Rheumatology (Oxford, England) · 2011Review
- Safety of biologic therapy in rheumatoid arthritis.Nature reviews. Rheumatology · 2011Review
- [Pregnancy under immunosuppression].Der Internist · 2011Review
- The treatment of rheumatoid arthritis during pregnancy.Rheumatology international · 2011Review
- Management of RA medications in pregnant patients.Nature reviews. Rheumatology · 2009Review
- Therapy: are TNF inhibitors safe in pregnancy?Nature reviews. Rheumatology · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
For female patients with rheumatoid arthritis, the availability of a host of new disease modifying antirheumatic drugs has raised important questions about fetal safety if a woman becomes pregnant while she is being treated. In addition, there is limited safety information regarding many of the older medications commonly used to treat rheumatoid arthritis in women of reproductive age. Current summary pregnancy risk information for selected medications used to treat rheumatoid arthritis is reviewed in the context of the pregnancy label category. In addition, the strengths and weaknesses of post-marketing strategies for developing new pregnancy safety information are described.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.